空间体学市场规模、份额、成长分析，按技术、按产品类型、按工作流程、按样本类型、按最终用途、按地区 - 行业预测，2025 年至 2032 年

2023 年全球空间体学市场规模价值为 3,650 亿美元，预计将从 2024 年的 4029.6 亿美元成长到 2032 年的 8,892.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.4%。

由于遗传疾病盛行率的不断上升、定序技术的进步以及创新研究投入的不断增加，空间体学市场正在经历显着的成长。这种变革性方法将重点从基因定序转移到分析细胞类型和生物标记的空间关係和相互作用。该领域的主要企业提供量化约 1,800 个 RNA 目标的解决方案，有效地将分子分析与组织的空间资料结合。这种空间基因组资讯对于开发诊断生物标记以辅助疾病识别和管理至关重要。因此，空间体学技术对于理解复杂的生物机制（包括组织组织和细胞调节）以及最终改善治疗策略和临床结果至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

空间组体学市场规模（依技术划分）

• 市场概况
• 空间转录组学
• 空间基因体学
• 空间蛋白质体学

空间组体学市场规模（依产品划分）

• 市场概况
• 装置
  • 按模式
  • 自动化
  • 半自动
  • 手动的
  • 按类型
  • 定序平台
  • 全球健康
  • 显微镜
  • 流式细胞技术
  • 质谱分析
  • 其他的
• 耗材
• 软体
  • 生物资讯学工具
  • 影像工具
  • 储存和管理资料库

空间组体学市场规模（按工作流程）

• 市场概况
• 样品製备
• 仪器分析
• 资料分析

空间组体学市场规模（依样本类型）

• 市场概况
• FFPE
• 新鲜冷冻

空间体学市场规模（依最终用途划分）

• 市场概况
• 学术和转化研究机构
• 製药和生物技术公司

空间组体学市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• 10x Genomics（US）
• Illumina（US）
• Fluidigm Corporation（US）
• Akoya Biosciences（formerly PerkinElmer）（US）
• S2 Genomics, Inc.（US）
• RareCyte, Inc.（US）
• ZEISS Group（Germany）
• Miltenyi Biotec（Germany）
• Bio-Techne Corporation（US）
• Visiopharm（Denmark）
• Indica Labs, Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Oxford Nanopore Technologies（UK）
• Takara Bio Inc.（Japan）

结论和建议

Global Spatial Omics Market size was valued at USD 365.0 billion in 2023 and is poised to grow from USD 402.96 billion in 2024 to USD 889.23 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

The spatial omics market is experiencing significant growth, driven by the increasing prevalence of genetic disorders, advancements in sequencing technologies, and heightened investment in innovative research. This transformative approach shifts focus from decoding gene sequences to analyzing the spatial positioning and interactions of cell types and biomarkers. Leading companies in the field are delivering solutions that quantify approximately 1,800 RNA targets, effectively merging molecular analysis with spatial data from tissues. This spatial genomic information is proving essential for developing diagnostic biomarkers that aid in disease identification and management. As such, spatial omics technology is crucial for understanding complex biological mechanisms, including tissue organization and cellular regulation, ultimately enhancing therapeutic strategies and clinical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segmental Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The Global Spatial Omics market is poised for significant growth, driven primarily by the increasing prevalence of genetic disorders that tend to be hereditary. As uncertainties surrounding health conditions rise, there is a growing desire among individuals to understand and detect these disorders through advanced omics technologies. This demand underscores the importance of spatial omics tools, which facilitate the identification and analysis of genetic anomalies within various biological samples. Consequently, the need for these innovative diagnostics and research solutions is propelling the expansion of the spatial omics market, making it a critical sector in addressing genetic health challenges.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces significant restraints that may impede its growth prospects. One major challenge is the shortage of skilled professionals with expertise in this emerging research domain, which is expected to limit advancements and further developments. Since Spatial Omics is still a relatively novel field, there is a lack of widespread acceptance and understanding, leading to cautious adoption among researchers and institutions. This limited recognition can stifle innovation and investment, ultimately hindering the overall expansion of the market during the forecast period. Addressing these issues will be crucial to unlocking the full potential of Spatial Omics.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is currently witnessing a significant uptick as the demand for advanced diagnostic tools grows, particularly in oncology. The innovative spatial omics techniques, which effectively elucidate the complex mechanisms governing cell interactions at tumor boundaries, are gaining traction due to their potential to enhance early malignancy detection. This trend is fueled by increasing investments in research and development, coupled with rising prevalence of cancers worldwide. Furthermore, the integration of spatial omics with existing genomic and transcriptomic technologies promises breakthroughs in personalized medicine, paving the way for a robust market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
  • By Mode
  • Automated
  • Semi-automated
  • Manual
  • By Type
  • Sequencing Platforms
  • IHC
  • Microscopy
  • Flow Cytometry
  • Mass Spectrometry
  • Others
• Consumables
• Software
  • Bioinformatics Tools
  • Imaging Tools
  • Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
• Instrumental Analysis
• Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• FFPE
• Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2025-2032)

• North America (Technology, Product, Workflow, Sample Type, End-use)
  • US
  • Canada
• Europe (Technology, Product, Workflow, Sample Type, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Workflow, Sample Type, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences (formerly PerkinElmer) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S2 Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RareCyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations